Company news
Ovid Therapeutics Inc. news in 2024
Ovid Therapeutics Inc.'s news releases, calls and decks from 2024, newest first.
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
December 1, 2024
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
November 11, 2024
Ovid Therapeutics to Host Investor Event
October 30, 2024
Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin
September 25, 2024
Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth
September 10, 2024
Ovid Therapeutics to Present at Upcoming September Investor Conferences
September 3, 2024
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
August 12, 2024
Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer
August 7, 2024
Ovid Therapeutics to Present at Upcoming August Investor Conferences
July 29, 2024
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
July 22, 2024
eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures
July 9, 2024
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
June 30, 2024
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
June 16, 2024
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
May 13, 2024
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 12, 2024
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 3, 2024
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
March 7, 2024
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 5, 2024
Decks in 2024
- Investor Day (November 2024)
Investor day · 87 slides · Nov 13, 2024